Myelin-oligodendrocyte glycoprotein antibody-associated disease
R Marignier, Y Hacohen, A Cobo-Calvo… - The Lancet …, 2021 - thelancet.com
Myelin-oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a recently
identified autoimmune disorder that presents in both adults and children as CNS …
identified autoimmune disorder that presents in both adults and children as CNS …
Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a review of clinical and MRI features, diagnosis, and management
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) is the
most recently defined inflammatory demyelinating disease of the central nervous system …
most recently defined inflammatory demyelinating disease of the central nervous system …
B cell depletion therapies in autoimmune disease: advances and mechanistic insights
DSW Lee, OL Rojas, JL Gommerman - Nature reviews Drug discovery, 2021 - nature.com
In the past 15 years, B cells have been rediscovered to be not merely bystanders but rather
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
active participants in autoimmune aetiology. This has been fuelled in part by the clinical …
[HTML][HTML] Myelin in the central nervous system: structure, function, and pathology
C Stadelmann, S Timmler… - Physiological …, 2019 - journals.physiology.org
Oligodendrocytes generate multiple layers of myelin membrane around axons of the central
nervous system to enable fast and efficient nerve conduction. Until recently, saltatory nerve …
nervous system to enable fast and efficient nerve conduction. Until recently, saltatory nerve …
Myelin oligodendrocyte glycoprotein antibodies in neurological disease
Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies (MOG-Abs) were first detected
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …
by immunoblot and enzyme-linked immunosorbent assay nearly 30 years ago, but their …
B cells in autoimmune and neurodegenerative central nervous system diseases
B cells are essential components of the adaptive immune system and have important roles
in the pathogenesis of several central nervous system (CNS) diseases. Besides producing …
in the pathogenesis of several central nervous system (CNS) diseases. Besides producing …
Reassessing B cell contributions in multiple sclerosis
There is growing recognition that B cell contributions to normal immune responses extend
well beyond their potential to become antibody-producing cells, including roles at the innate …
well beyond their potential to become antibody-producing cells, including roles at the innate …
Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study
Y Takai, T Misu, K Kaneko, N Chihara, K Narikawa… - Brain, 2020 - academic.oup.com
Conformation-sensitive antibodies against myelin oligodendrocyte glycoprotein (MOG) are
detectable in patients with optic neuritis, myelitis, opticomyelitis, acute or multiphasic …
detectable in patients with optic neuritis, myelitis, opticomyelitis, acute or multiphasic …
Acute disseminated encephalomyelitis: updates on an inflammatory CNS syndrome
D Pohl, G Alper, K Van Haren, AJ Kornberg… - Neurology, 2016 - AAN Enterprises
Acute disseminated encephalomyelitis (ADEM) is an immune-mediated demyelinating CNS
disorder with predilection to early childhood. ADEM is generally considered a monophasic …
disorder with predilection to early childhood. ADEM is generally considered a monophasic …
Disease course and treatment responses in children with relapsing myelin oligodendrocyte glycoprotein antibody–associated disease
Y Hacohen, YY Wong, C Lechner, M Jurynczyk… - JAMA …, 2018 - jamanetwork.com
Importance Myelin oligodendrocyte glycoprotein antibodies (MOG-Abs) are consistently
identified in a range of demyelinating disorders in adults and children. Current therapeutic …
identified in a range of demyelinating disorders in adults and children. Current therapeutic …